Peter Feinberg
Directeur/Membre du Conseil chez IMMUNEERING CORPORATION
Fortune : 1 M $ au 30/06/2024
Profil
Mr. Peter Feinberg is an Independent Director at Notable Labs Ltd., an Independent Director at Immuneering Corp., a Co-Founder at Boxcar PMJ LLC and a Partner at Boxcar Partners.
He is on the Board of Directors at Notable Labs Ltd., Immuneering Corp.
and Sporos Bioventures, Inc. Mr. Feinberg was previously employed as a Co-Founder by BridgeBio Pharma, Inc., a MD, Head-Institutional Equities Trading by Oppenheimer & Co., Inc., and a Founder by North Coast Partners LLP.
He received his undergraduate degree from Whittier College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/06/2024 | 1 096 064 ( 3,70% ) | 1 M $ | 30/06/2024 | |
0,42% | 08/05/2024 | 40 247 ( 0,42% ) | 25 315 $ | 30/06/2024 |
Postes actifs de Peter Feinberg
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNEERING CORPORATION | Directeur/Membre du Conseil | 01/01/2021 |
Boxcar PMJ LLC
 Boxcar PMJ LLC Boxcar PMJ LLC is an Independent Venture Capital firm founded in 2019 by Peter Feinberg. The firm is headquartered in the US. | Fondateur | 01/06/2019 |
Sporos Bioventures, Inc.
 Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Sporos Bioventures, Inc. is a private biopharmaceutical company based in Houston, TX. Sporos Bioventures, Inc. aims to transform the drug development process by identifying novel disease mechanisms and strategically deploying talent, capital, and access to operational resources to catalyze the development of breakthrough medicines. Sporos' current pipeline is diversified across three business units and includes multiple clinical-stage candidates that are being investigated for the treatment of multiple indications in cancer and immune disease. The company provides centralized expertise, resources, and core infrastructure so that the portfolio companies can focus primarily on their research development programs. The company was founded by Peter Feinberg, Ronald A. DePinho, Jeno Gyuris, Joseph Kekst, Harold Levy, Alex M. Cranberg, Louis Feinberg, Michael S. Wyzga, Dana Levy, and the CEO is Stephen Rubino. | Fondateur | 01/04/2020 |
| Boxcar Partners | Corporate Officer/Principal | 01/06/2019 |
Anciens postes connus de Peter Feinberg
| Sociétés | Poste | Fin |
|---|---|---|
Oppenheimer & Co., Inc.
 Oppenheimer & Co., Inc. Investment ManagersFinance Oppenheimer & Co., Inc. provides security brokerage services. It also offers investment banking and advice to high net worth investors, individuals, businesses and institutions. The company is headquartered in New York, NY. | Corporate Officer/Principal | 31/01/2015 |
| North Coast Partners LLP | Fondateur | - |
| BRIDGEBIO PHARMA, INC. | Fondateur | - |
Formation de Peter Feinberg
| Whittier College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| IMMUNEERING CORPORATION | Health Technology |
| BRIDGEBIO PHARMA, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Oppenheimer & Co., Inc.
Oppenheimer & Co., Inc. Investment ManagersFinance Oppenheimer & Co., Inc. provides security brokerage services. It also offers investment banking and advice to high net worth investors, individuals, businesses and institutions. The company is headquartered in New York, NY. | Finance |
Boxcar PMJ LLC
Boxcar PMJ LLC Boxcar PMJ LLC is an Independent Venture Capital firm founded in 2019 by Peter Feinberg. The firm is headquartered in the US. | |
Sporos Bioventures, Inc.
Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Sporos Bioventures, Inc. is a private biopharmaceutical company based in Houston, TX. Sporos Bioventures, Inc. aims to transform the drug development process by identifying novel disease mechanisms and strategically deploying talent, capital, and access to operational resources to catalyze the development of breakthrough medicines. Sporos' current pipeline is diversified across three business units and includes multiple clinical-stage candidates that are being investigated for the treatment of multiple indications in cancer and immune disease. The company provides centralized expertise, resources, and core infrastructure so that the portfolio companies can focus primarily on their research development programs. The company was founded by Peter Feinberg, Ronald A. DePinho, Jeno Gyuris, Joseph Kekst, Harold Levy, Alex M. Cranberg, Louis Feinberg, Michael S. Wyzga, Dana Levy, and the CEO is Stephen Rubino. | Health Services |
| Boxcar Partners | |
| North Coast Partners LLP |
